Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 458.26
-12.85 (-2.73%)
Dec 5, 2025, 5:01 PM BST
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 45.43 billion as of December 5, 2025. Its market cap has increased by 90.54% in one year.
Market Cap
45.43B
Enterprise Value
45.46B
Revenue
2.39B
Ranking
n/a
PE Ratio
1,401.64
Stock Price
458.26
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 45.43B, an increase of 71,748.69%. That is a compound annual growth rate of 35.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.49B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |